Mach, François

Title Year Hits Downloads
Anti-apolipoprotein A-1 autoantibodies are associated with immunodeficiency and systemic inflammation in HIV patients 2018 58 1
Impact of long distance rowing on biological health: A pilot study 2018 68 0
Differential Association of Cx37 and Cx40 Genetic Variants in Atrial Fibrillation with and without Underlying Structural Heart Disease 2018 154 26
Impact of CD14 Polymorphisms on Anti-Apolipoprotein A-1 IgG-Related Coronary Artery Disease Prediction in the General Population 2017 53 0
The fear of dying and occurrence of posttraumatic stress symptoms after an acute coronary syndrome: A prospective observational study 2017 207 124
GPR55 agonist lysophosphatidylinositol and lysophosphatidylcholine inhibit endothelial cell hyperpolarization via GPR-independent suppression of Na + -Ca 2+ exchanger and endoplasmic reticulum Ca 2+ refilling 2017 27 18
Increased Proangiogenic Activity of Mobilized CD34+ Progenitor Cells of Patients With Acute ST-Segment–Elevation Myocardial Infarction Role of Differential MicroRNA-378 Expression 2017 27 1
Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease 2017 39 0
Profiling and validation of circulating microRNAs for cardiovascular events in patients presenting with ST-segment elevation myocardial infarction 2017 24 1
Activité physique au long cours après un infarctus du myocarde : un défi permanent 2017 71 20
4D cardiac imaging at clinical 3.0T provides accurate assessment of murine myocardial function and viability 2017 134 2
Alamandine abrogates neutrophil degranulation in atherosclerotic mice 2017 24 3
Anti-Apolipoprotein A-1 IgG Predict All-Cause Mortality and Are Associated with Fc Receptor-Like 3 Polymorphisms 2017 49 13
Early Discharge in Low-Risk Patients Hospitalized for Acute Coronary Syndromes: Feasibility, Safety and Reasons for Prolonged Length of Stay 2016 144 95
Association between anti-apolipoprotein A-1 antibodies and cardiovascular disease in the general population. Results from the CoLaus study 2016 179 6
Anti-ApoA-1 IgG serum levels predict worse post-stroke outcomes 2016 204 6
Vitamin D receptor is expressed within human carotid plaques and correlates with pro-inflammatory M1 macrophages 2016 165 0
Treatment with the GPR55 antagonist CID16020046 increases neutrophil activation in mouse atherogenesis 2016 299 1
Health utility indexes in patients with acute coronary syndromes 2016 156 62
Prognostic value of PCSK9 levels in patients with acute coronary syndromes 2016 228 2
Myeloid IL-10 receptor signalling as pro-atherogenic factor modulating cholesterol homeostasis 2016 142 2
Anti-apolipoprotein A-1 auto-antibodies as active modulators of atherothrombosis 2016 319 153
Sphingosine-1-phosphate reduces ischaemia-reperfusion injury by phosphorylating the gap junction protein Connexin43 2016 236 3
Treatment with anti-RANKL antibody reduces infarct size and attenuates dysfunction impacting on neutrophil-mediated injury 2016 189 1
Pre-hospital alarm activation for STEMI patients undergoing primary percutaneous coronary intervention in the era of transradial procedures 2016 46 0
Intraplaque Expression of C-Reactive Protein Predicts Cardiovascular Events in Patients with Severe Atherosclerotic Carotid Artery Stenosis 2016 49 7
Treatment with sulphated galactan inhibits macrophage chemotaxis and reduces intraplaque macrophage content in atherosclerotic mice 2015 198 0
Role of matrix metalloproteinases in animal models of ischemic stroke 2015 160 0
The Human Autoantibody Response to Apolipoprotein A-I Is Focused on the C-Terminal Helix: A New Rationale for Diagnosis and Treatment of Cardiovascular Disease? 2015 165 63
Update on the role of neutrophils in atherosclerotic plaque vulnerability 2015 147 0
Pathophysiology and Treatments of Oxidative Injury in Ischemic Stroke: Focus on the Phagocytic NADPH Oxidase 2 2015 221 0
Update on the role of angiotensin in the pathophysiology of coronary atherothrombosis 2015 154 0
Thromboembolic events 7-11 years after catheter ablation of atrial fibrillation 2015 182 0
Treatment with recombinant tissue plasminogen activator (r-TPA) induces neutrophil degranulation in vitro via defined pathways 2015 340 4
Diminazene protects corpus cavernosum against hypercholesterolemia-induced injury 2015 190 0
Editorial: update on inflammatory targets modulating atherogenesis 2015 141 0
Diminazene enhances stability of atherosclerotic plaques in ApoE-deficient mice 2015 190 1
Use and role of monoclonal antibodies and other biologics in preventive cardiology 2015 215 63
Treatment with KLEPTOSE® CRYSMEB reduces mouse atherogenesis by impacting on lipid profile and Th1 lymphocyte response 2015 282 0
Impact of propofol anaesthesia on cytokine expression profiles in the developing rat brain: a randomised placebo-controlled experimental in-vivo study 2015 184 0
Leptin/adiponectin ratio predicts post-stroke neurological outcome 2015 185 1
Anti-apoA-1 auto-antibodies increase mouse atherosclerotic plaque vulnerability, myocardial necrosis and mortality triggering TLR2 and TLR4 2015 196 4
Stairs instead of elevators at the workplace decreases PCSK9 levels in a healthy population 2015 269 0
Improving reconstituted HDL composition for efficient post-ischemic reduction of ischemia reperfusion injury 2015 253 50
Expected impact of applying new 2013 AHA/ACC cholesterol guidelines criteria on the recommended lipid target achievement after acute coronary syndromes 2015 119 91
Genetic deletion of the adaptor protein p66Shc increases susceptibility to short-term ischaemic myocardial injury via intracellular salvage pathways 2015 293 2
Genetic studies of body mass index yield new insights for obesity biology 2015 139 0
Gastric bypass in morbid obese patients is associated with reduction in adipose tissue inflammation via N-oleoylethanolamide (OEA)-mediated pathways 2015 324 0
Serum osteopontin levels are upregulated and predict disability after an ischaemic stroke 2015 213 0
Mon patient est trop âgé pour une statine : mythes et réalités 2015 128 0
The role of adipocytokines in atherogenesis and atheroprogression 2015 155 0
Left atrial thrombosis in an anticoagulated patient after bioprosthetic valve replacement: Report of a case 2014 160 0
Analysis of the expression of nine secreted matrix metalloproteinases and their endogenous inhibitors in the brain of mice subjected to ischaemic stroke 2014 246 0
Nicotinamide phosphoribosyltransferase inhibition reduces intraplaque CXCL1 production and associated neutrophil infiltration in atherosclerotic mice 2014 296 0
Update on selective treatments targeting neutrophilic inflammation in atherogenesis and atherothrombosis 2014 242 0
Update on the efficacy of statin treatment in acute coronary syndromes 2014 208 0
Cannabinoid receptor type 2 activation in atherosclerosis and acute cardiovascular diseases 2014 392 0
Left atrial dissection after mitral valve replacement 2014 273 0
Inferior vena cava parameters predict re-admission in ischaemic heart failure 2014 218 0
Treatment with Angiotensin-(1-7) reduces inflammation in carotid atherosclerotic plaques 2014 189 0
Endothelial Cx40 limits myocardial ischaemia/reperfusion injury in mice 2014 291 4
Treatment with Evasin-3 abrogates neutrophil-mediated inflammation in mouse acute pancreatitis 2014 230 0
Statin treatment is associated with reduction in serum levels of receptor activator of NF-κB ligand and neutrophil activation in patients with severe carotid stenosis 2014 335 142
Potential pathophysiological role for the vitamin D deficiency in essential hypertension 2014 219 0
Implementation strategies of Systems Medicine in clinical research and home care for cardiovascular disease patients 2014 190 0
Angiotensin II receptor antagonists in acute coronary syndromes 2014 160 0
Advanced glycation end products play adverse proinflammatory activities in osteoporosis 2014 184 358
Recombinant tissue plasminogen activator enhances microglial cell recruitment after stroke in mice 2014 308 164
La testostérone : un traitement pour la prévention des maladies cardiovasculaires ? 2014 189 0
Improvement in coronary circulatory function in morbidly obese individuals after gastric bypass-induced weight loss: relation to alterations in endocannabinoids and adipocytokines 2013 250 0
The vulnerable coronary plaque: update on imaging technologies 2013 107 0
Discovery and refinement of loci associated with lipid levels 2013 247 0
Treatment with Evasin-3 reduces atherosclerotic vulnerability for ischemic stroke, but not brain injury in mice 2013 251 0
Pathophysiological role of neutrophils in acute myocardial infarction 2013 187 0
Inflammation is a key pathophysiological feature of metabolic syndrome 2013 167 52
Pathophysiological role of the renin-angiotensin system on erectile dysfunction 2013 172 85
Update on the pathophysiological activities of the cardiac molecule cardiotrophin-1 in obesity 2013 188 48
Treatment with CB2 agonist JWH-133 reduces histological features associated with erectile dysfunction in hypercholesterolemic mice 2013 131 0
Role of mitogen-activated protein kinase pathways in multifactorial adverse cardiac remodeling associated with metabolic syndrome 2013 188 50
An oral formulation of angiotensin-(1-7) reverses corpus cavernosum damages induced by hypercholesterolemia 2013 183 0
Alpha-fetoprotein: a controversial prognostic biomarker for small hepatocellular carcinoma 2013 197 0
Glucagon-like peptide-1 triggers protective pathways in pancreatic beta-cells exposed to glycated serum 2013 180 0
Update on the protective molecular pathways improving pancreatic beta-cell dysfunction 2013 229 51
Cardiopathies congénitales de l'âge adulte: nouvelle population de patients, prise en charge multidisciplinaire 2013 204 0
Role of NADPH oxidase isoforms NOX1, NOX2 and NOX4 in myocardial ischemia/reperfusion injury 2013 229 0
Treatment with the CC chemokine-binding protein Evasin-4 improves post-infarction myocardial injury and survival in mice 2013 336 0
Evidence on the pathogenic role of auto-antibodies in acute cardiovascular diseases 2013 122 0
Anti-apolipoprotein A-1 autoantibodies as biomarker for atherosclerosis burden in patients with periodontitis 2013 341 3
Role of the renin-angiotensin system on abdominal aortic aneurysms 2013 150 0
Serum levels of anti-apolipoprotein A-1 auto-antibodies and myeloperoxidase as predictors of major adverse cardiovascular events after carotid endarterectomy 2013 307 0
An emerging role of glucagon-like peptide-1 in preventing advanced-glycation-end-product-mediated damages in diabetes 2013 169 162
Update on evidence for treatment with ranolazine in stable angina 2013 144 0
Inhibition of nicotinamide phosphoribosyltransferase reduces neutrophil-mediated injury in myocardial infarction 2013 350 390
Role of matrix metalloproteinase-8 in atherosclerosis 2013 169 37
The liver and the kidney: two critical organs influencing the atherothrombotic risk in metabolic syndrome 2013 155 0
Update on the endocannabinoid-mediated regulation of gelatinase release in arterial wall physiology and atherosclerotic pathophysiology 2012 229 0
Matching between regional coronary vasodilator capacity and corresponding circumferential strain in individuals with normal and increasing body weight 2012 273 11
Statins and stent thrombosis 2012 159 0
Antiplatelet drug response status does not predict recurrent ischemic events in stable cardiovascular patients: results of the Antiplatelet Drug Resistances and Ischemic Events study 2012 305 3
Fondaparinux versus enoxaprin in the management of acute coronary syndromes in Switzerland: A cost comparison analysis 2012 183 1
Antiapolipoprotein A-1 IgG chronotropic effects require nongenomic action of aldosterone on L-type calcium channels 2012 303 2
Molecular imaging of matrix metalloproteinases in atherosclerotic plaques 2012 119 0
Elevated E-selectin and diastolic blood pressure in diabetic children 2012 272 0
Receptor activator of NF- κB ligand (RANKL) increases the release of neutrophil products associated with coronary vulnerability 2012 350 1
Role of renin-angiotensin system in inflammation, immunity and aging 2012 218 0
High time-resolved cardiac functional imaging using temporal regularization for small animal on a clinical 3T scanner 2012 246 2
Serum resistin and inflammatory and endothelial activation markers in obese adolescents 2012 268 0
The activation of the cannabinoid receptor type 2 reduces neutrophilic protease-mediated vulnerability in atherosclerotic plaques 2012 312 2
Pathophysiological role of inflammatory molecules in paediatric ischaemic brain injury 2012 228 0
CC chemokine CCL5 plays a central role impacting infarct size and post-infarction heart failure in mice 2012 301 3
Coronary Vasomotor Control in Obesity and Morbid Obesity 2012 325 343
Toll-like receptor 7 protects from atherosclerosis by constraining "inflammatory" macrophage activation 2012 164 0
Matrix metalloproteinase-9: a deleterious link between hepatic ischemia-reperfusion and colorectal cancer 2012 163 0
Autoantibodies against apolipoprotein A-1 and phosphorylcholine for diagnosis of non-ST-segment elevation myocardial infarction 2012 270 2
Anti-apolipoprotein A-1 IgG levels predict coronary artery calcification in obese but otherwise healthy individuals 2012 246 93
Inflammatory cardiovascular risk biomarkers: update on novelties and limitations 2012 169 0
Role of cytokines and chemokines in non-alcoholic fatty liver disease 2012 79 0
Manganese kinetics demonstrated double contrast in acute but not in chronic infarction in a mouse model of myocardial occlusion reperfusion 2012 261 1
Editorial: update on inflammatory processes governing atherosclerotic plaque vulnerability and reperfusion injury 2012 152 0
Shear stress modulates the expression of the atheroprotective protein Cx37 in endothelial cells 2012 286 7
Statins in the treatment of acute ischemic stroke 2012 173 0
Lack of association between connexin40 polymorphisms and coronary artery disease 2012 198 5
Update on the Pathophysiological Role of Intracellular Signaling Pathways in Atherosclerotic Plaques and Ischemic Myocardium 2012 182 0
The angiotensin-converting enzyme 2/angiotensin-(1-7)/Mas receptor axis: a potential target for treating thrombotic diseases 2012 97 0
Curing by Burning: What to expect from renal denervation in the treatment of arterial hypertension 2012 276 0
Update on the role of cannabinoid receptors after ischemic stroke 2012 165 1
Mass spectrometry for the evaluation of cardiovascular diseases based on proteomics and lipidomics 2011 307 1
Anti-Apolipoprotein A-1 auto-antibodies are active mediators of atherosclerotic plaque vulnerability 2011 264 2
Elevated endocannabinoid plasma levels are associated with coronary circulatory dysfunction in obesity 2011 294 0
Rapid detection of genetic variants in hypertrophic cardiomyopathy by custom DNA resequencing array in clinical practice 2011 279 0
Acipimox reduces circulating levels of insulin and associated neutrophilic inflammation in metabolic syndrome 2011 276 0
Sélection et suivi prétransplantation des patients candidats à la greffe cardique en Suisse romande 2011 284 0
Stairs instead of elevators at workplace: cardioprotective effects of a pragmatic intervention 2010 522 1
In vivo labelling of resting monocytes in the reticuloendothelial system with fluorescent iron oxide nanoparticles prior to injury reveals that they are mobilized to infarcted myocardium 2010 212 0
La cardiologie dans le rythme 2010 234 0
Systemic and intraplaque mediators of inflammation are increased in patients symptomatic for ischemic stroke 2010 273 0
Le clopidogrel et ses différents sets: existe-t-il une pertinence clinique? 2010 241 0
Single administration of the CXC chemokine-binding protein Evasin-3 during ischemia prevents myocardial reperfusion injury in mice 2010 272 0
Prehospital emergency physician activation of interventional cardiology team reduces door-to-balloon time in ST-elevation myocardial infarction 2010 241 0
Clinical predictors of dual aspirin and clopidogrel poor responsiveness in stable cardiovascular patients from the ADRIE study 2010 246 0
Un projet multicentrique suisse pour améliorer la prévention et la récidive après un syndrome coronarien aigu 2010 274 0
Myocardial infarction quantification with Manganese-Enhanced MRI (MEMRI) in mice using a 3T clinical scanner 2010 207 2
Anti-apolipoprotein A-1 IgG as an independent cardiovascular prognostic marker affecting basal heart rate in myocardial infarction 2010 292 1
Chemokine CCL5/RANTES inhibition reduces myocardial reperfusion injury in atherosclerotic mice 2010 291 0
Anti-apolipoprotein A-1 IgG predicts major cardiovascular events in patients with rheumatoid arthritis 2010 303 2
Combined evaluation of myocardial perfusion and coronary morphology in the identification of subclinical CAD. Radiation exposure of 13N-ammonia PET/CT 2010 274 0
Structural epicardial disease and microvascular function are determinants of an abnormal longitudinal myocardial blood flow difference in cardiovascular risk individuals as determined with PET/CT 2010 275 7
Novel treatment strategy with direct renin inhibition against heart failure 2010 223 0
High-Throughput Phospholipidic Fingerprinting by Online Desorption of Dried Spots and Quadrupole-Linear Ion Trap Mass Spectrometry: Evaluation of Atherosclerosis Biomarkers in Mouse Plasma 2010 273 0
Receptor activator of nuclear factor kappa B ligand/osteoprotegerin pathway is a promising target to reduce atherosclerotic plaque calcification 2010 367 0
Inflammation accelerates atherosclerotic processes in obstructive sleep apnea syndrome (OSAS) 2010 259 11
New evidence for nicotinic acid treatment to reduce atherosclerosis 2010 673 0
Coronary artery calcification and cardiovascular risk: the role of RANKL/OPG signalling 2010 238 0
Acute coronary syndrome and its antithrombotic treatment: focus on aspirin and clopidogrel resistance 2009 193 0
CB(2) cannabinoid receptor activation is cardioprotective in a mouse model of ischemia/reperfusion 2009 322 0
Statins inhibit C-reactive protein-induced chemokine secretion, ICAM-1 upregulation and chemotaxis in adherent human monocytes 2009 268 0
HIV increases markers of cardiovascular risk: results from a randomized, treatment interruption trial 2009 303 0
Oxaprozin-induced apoptosis on CD40 ligand-treated human primary monocytes is associated with the modulation of defined intracellular pathways 2009 215 0
Chlorhexidine prevents hypochlorous acid-induced inactivation of alpha1-antitrypsin 2009 315 0
Effects of statin therapy according to plasma high-sensitivity C-reactive protein concentration in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA): a retrospective analysis 2009 199 0
Noninvasive stress testing of myocardial perfusion defects: head-to-head comparison of thallium-201 SPECT to MRI perfusion 2009 272 8
Suivi du patient après transplantation cardiaque : monitoring et adaptation de l’immunosuppression 2009 264 0
Obstructive sleep apnea and atherosclerosis 2009 242 0
Swimming prevents vulnerable atherosclerotic plaque development in hypertensive 2-kidney, 1-clip mice by modulating angiotensin II type 1 receptor expression independently from hemodynamic changes 2009 244 0
Regulation and possible role of endocannabinoids and related mediators in hypercholesterolemic mice with atherosclerosis 2009 253 0
Percutaneous retrieval of intravascular and intracardiac foreign bodies with a dedicated three-dimensional snare: a 3-year single center experience 2009 260 0
Ezetimibe/simvastatin 2009 186 0
Statins, ACE inhibitors and ARBs in cardiovascular disease 2009 229 0
The inflammatory response as a target to reduce myocardial ischaemia and reperfusion injury 2009 238 0
The renin-angiotensin system modulates inflammatory processes in atherosclerosis: evidence from basic research and clinical studies 2009 244 0
Update on statin-mediated anti-inflammatory activities in atherosclerosis 2009 218 10
Stair use for cardiovascular disease prevention 2009 303 0
Common inflammatory mediators orchestrate pathophysiological processes in rheumatoid arthritis and atherosclerosis 2009 251 5
Atherosclerosis is an inflammatory disease 2009 205 7
Effect of blockage of the endocannabinoid system by CB(1) antagonism on cardiovascular risk 2009 183 0
Update on therapeutic strategies to increase adiponectin function and secretion in metabolic syndrome 2009 244 0
The role of the endocannabinoid system in atherosclerosis 2008 252 2
A DNA resequencing array for pathogenic mutation detection in hypertrophic cardiomyopathy 2008 302 0
C-reactive protein (CRP) induces chemokine secretion via CD11b/ICAM-1 interaction in human adherent monocytes 2008 275 0
Emerging Roles for Connexins in Hypertension 2008 276 0
A novel RANTES antagonist prevents progression of established atherosclerotic lesions in mice 2008 277 2
PARP1 is required for adhesion molecule expression in atherogenesis 2008 252 66
Biological effect of increased maintenance dose of clopidogrel in cardiovascular outpatients and influence of the cytochrome P450 2C19*2 allele on clopidogrel responsiveness 2008 237 0
Tumor necrosis factor-alpha (TNF-alpha) induces integrin CD11b/CD18 (Mac-1) up-regulation and migration to the CC chemokine CCL3 (MIP-1alpha) on human neutrophils through defined signalling pathways 2008 304 1
Anti-(apolipoprotein A-1) IgGs are associated with high levels of oxidized low-density lipoprotein in acute coronary syndrome 2008 298 9
Adiponectin and adaptive immunity: linking the bridge from obesity to atherogenesis 2008 241 2
Cannabinoid receptors in acute and chronic complications of atherosclerosis 2008 240 0
New evidences for C-reactive protein (CRP) deposits in the arterial intima as a cardiovascular risk factor 2008 245 88
CB2 cannabinoid receptor agonist JWH-015 modulates human monocyte migration through defined intracellular signaling pathways 2008 259 2
Renin-angiotensin system blockade and contrast-induced renal toxicity 2008 251 0
Insulin resistance: a proinflammatory state mediated by lipid-induced signaling dysfunction and involved in atherosclerotic plaque instability 2008 247 196
Atorvastatin treatment and vaccination efficacy 2007 254 0
Immunization of LDL receptor-deficient mice with beta2-glycoprotein 1 or human serum albumin induces a more inflammatory phenotype in atherosclerotic plaques 2007 284 91
Soluble CD40 ligand in prediction of acute severe pancreatitis 2006 260 295
Late cardiac tamponade after percutaneous closure of a patent foramen ovale 2005 244 79
L'apport de la génétique moléculaire en cardiologie clinique : l'exemple de la cardiomyopathie hypertrophique 2005 214 1
Presence of autoantibodies to apolipoprotein A-1 in patients with acute coronary syndrome further links autoimmunity to cardiovascular disease 2004 157 0
Role of Toll-like receptor 4 on pancreatic and pulmonary injury in a mice model of acute pancreatitis associated with endotoxemia 2004 270 1
Reduced connexin43 expression inhibits atherosclerotic lesion formation in low-density lipoprotein receptor-deficient mice 2003 195 1
Cd40 ligand-deficient mice are protected against cerulein-induced acute pancreatitis and pancreatitis-associated lung injury 2001 236 0
44604 3742